Tradestie Institutional Equity Comparison Engine

RAPP vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PVLA Overall Edge

PVLA Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RAPP trades at N/M Forward P/E with -838.1% operating margin (+0.0% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, RAPP sits in BREAKDOWN (6th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
RAPP N/M vs PVLA N/M Fwd P/E
Growth & Margin Winner PVLA
Op Margin -838.1% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner PVLA
1Y +2.5% vs +80.2% ยท 52W Pos 10% vs 68%
Options & Structure Winner PVLA
BREAKDOWN (6th %ile IV) vs CONSOLIDATION (2nd %ile IV)
RAPP NASDAQ
Rapport Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$25.29
-3.29% 1D
Market Cap $1.5B
1M Return -8.27%
1Y Return +2.51%
Forward P/E N/M
Unified AI Score
51.5 / 100 HOLD
Tech 64.0 Fund 60.0 Flow 68.0 Mom 58.9
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RAPP +2.51% PVLA +80.16% Spread: +77.65 pp (PVLA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RAPP TTM Op. Margin: -838.1% PVLA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RAPP vs PVLA. Trailing 12-month operating profitability (RAPP -838.1% vs PVLA 0.0%) and valuation multiples (RAPP N/M vs PVLA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RAPP (2) vs PVLA (4)
Institutional Metric RAPP PVLA Criterion Row Winner
Market Capitalization Scale $1.5B $2.2B Larger Scale PVLA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -838.1% 0.0% Higher Margin PVLA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -33.3% -63.4% Higher ROE RAPP
52-Week Range Position Momentum 10% ($22โ€“$53) 68% ($72โ€“$180) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 109% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk PVLA
Unified Institutional Score Composite Signal 51.5 / 100 (HOLD) 48.2 / 100 (HOLD) Higher Composite RAPP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RAPP vs PVLA Buy Guide
RAPP BREAKDOWN
133d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live RAPP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RAPP nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.